Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study

Journal of Infectious Diseases

Volumn 186, Issue 4, 2002, Pages 462-469

  Giuliano, Anna R ^a,b   Harris, Robin ^a,b   Sedjo, Rebecca L ^a   Baldwin, Susie ^a,b   Roe, Denise ^a,b   Papenfuss, Mary R ^a   Abrahamsen, Martha ^a   Inserra, Paula ^c   Olvera, Sandra ^d   Hatch, Kenneth ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d Martek Biosciences Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX; VIRUS IDENTIFICATION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; CERVIX UTERI; COHORT STUDIES; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; INCIDENCE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 0037103398     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/341782     Document Type: Article

References (25)

1. Prevalence of human Papillomavirus in cervical cancer: A worldwide perspective
2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
3. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection
4. Natural history of cervicovaginal papillomavirus infection in young women
5. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia
6. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine
7. Persistence of HPV 16 antibodies after immunization with HPV 16 L1 virus-like particle (VLP) vaccines
8. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial
9. The role of nutrients in the prevention of cervical dysplasia and cancer
10. Antioxidant nutrients: Associations with persistent human papillomavirus infection
11. Uterine cervical cancer risk in cigarette smokers: A meta-analytic study
12. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection
13. HPV 16 and cigarette smoking as risk factors for high grade cervical intra-epithelial neoplasia
14. Improved amplification of genital human papillomaviruses
15. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method
16. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women
17. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer
18. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females
19. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities
20. Persistence of type-specific human papillomavirus infection among cytologically normal women
21. Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology
22. Human papillomavirus infection is transient in young women: A population-based cohort study
23. Determinants of persistent detection of human papillomavirus DNA in the uterine cervix
24. Follow-up evaluation of cervicovaginal human papillomavirus infection in adolescents
25. Colposcopic and histologic findings and human papillomavirus (HPV) DNA test variability in young women positive for HPV DNA